A phase-II study of pegylated interferon alfa-2b for patients with metastatic renal cell carcinoma and removal of the primary tumor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase-II study of pegylated interferon alfa-2b for patients with metastatic renal cell carcinoma and removal of the primary tumor

Published:2004-12-31 Issue:7 Volume:54 Page:713-719
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Bex Axel,Mallo Henk,Kerst Martijn,Haanen John,Horenblas Simon,Gast Gijsbert C. de

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-004-0630-9.pdf

Reference20 articles.

1. Bukowski R, Ernstoff MS, Gore ME, Nemunaitis JJ, Amato RJ, Gupta SK, Tendler CL (2002) Pegylated interferon alfa-2b treatment for patients with solid tumors: a phase-I/II study. J Clin Oncol 20:3841–3949

2. Bukowski R, Tendler CL, Cutler D, Rose E, Laughlin M, Statkevich P (2002) Treating cancer with PEG Intron: pharmakokinetic profile and dosing guidelines for an improved interferon-alpha-2b formulation. Cancer 95:389–396

3. Flanigan RC, Salmon SE, Blumenstein BA, Bearman SI, Roy V, McGrath PC, Caton JRj, Munshi N, Crawford ED (2001) Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell carcinoma. N Engl J Med 345:1655–1659

4. Glue P, Fang JW, Rouzier-Panis R, Raffanel C, Sabo R, Gupta SK, Salfi M, Jacobs S (2000) Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group. Clin Pharmacol Ther 68:556–567

5. Kantarjian HM, O’Brien S, Anderlini P, Talpaz M (1996) Treatment of myelogenous leukemia: current status and investigational options. Blood 87:3069–3081

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facile synthesis of Fe3O4@polyethylenimine with peroxidase-like activity for highly sensitive detection of interferon α-2b;Science China Materials;2023-09-07

2. Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications;Current Oncology Reports;2022-02-10

3. Pegylated-Interferon-alpha treatment modifying T cell cytokine profile in tumor microenvironment of patients with cervical intraepithelial neoplasia;European Journal of Gynaecological Oncology;2021

4. Ιmpact of sunitinib-induced hypothyroidism on survival of patients with metastatic renal cancer;BMC Cancer;2019-04-30

5. Dose-escalation study evaluating pegylated interferon alpha-2a in patients with cutaneous T-cell lymphoma;Journal of the European Academy of Dermatology and Venereology;2017-07-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3